Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study.

T. Gaisl (Zurich, Switzerland), P. Rejmer (Zurich, Switzerland), S. Stämpfli (Zurich, Switzerland), F. Tanner (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)

Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Gaisl (Zurich, Switzerland), P. Rejmer (Zurich, Switzerland), S. Stämpfli (Zurich, Switzerland), F. Tanner (Zurich, Switzerland), M. Kohler (Zurich, Switzerland). Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study.. 415

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020




Prevalence of obstructive sleep apnoea in patients with thoracic aortic aneurysm: A prospective, parallel cohort study.
Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep
Year: 2019


Obstructive sleep apnoea and the progression of thoracic aortic aneurysm: a prospective cohort study
Source: Eur Respir J, 57 (5) 2003322; 10.1183/13993003.03322-2020
Year: 2021



High obstructive sleep apnea risk in patients with type A aortic dissection
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018

Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Thoracic aortic aneurysms: expanding the potential cardiovascular consequences of obstructive sleep apnoea
Source: Eur Respir J, 57 (5) 2004440; 10.1183/13993003.04440-2020
Year: 2021



Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Is acute pulmonary embolism more severe in the presence of obstructive sleep apnoea? Results from a cohort study.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Prevalence of obstructive sleep apnoea and its association with aortic root dilatation in patients with Marfan‘s syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Increased risk of stroke in patients with coronary artery disease and sleep apnea – a 10 year follow-up.
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008


Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017


Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020

Apolipoprotein E polymorphisms and incident arterial hypertension in obstructive sleep apnea patients A prospective cohort study
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018

Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020